CDMO: EUROAPI Completes Acquisition of Biano
22 November 2023 - 3:45AM
Business Wire
Regulatory News:
EUROAPI (Paris:EAPI) today announced the completion of the
acquisition of BianoGMP (“Biano”), strengthening its CDMO expertise
in the high-growth oligonucleotide market.
This acquisition further differentiates EUROAPI’s value
proposition to support a broader client base across the whole
oligonucleotide development continuum, from research to
commercialization.
“We are delighted to welcome the talented people of Biano,” said
Viviane Monges, EUROAPI’s Chief Executive Officer. “Biano has
demonstrated a strong commitment to supporting clients with
innovative oligonucleotide developments. I look forward to all that
we will achieve together to sustainably meet clients’ and patients’
needs around the world through our complementarities.”
As planned, Biano will retain its corporate brand and become a
EUROAPI company.
About EUROAPI
EUROAPI is focused on reinventing active ingredient solutions to
sustainably meet customers’ and patients’ needs around the world.
We are a leading player in active pharmaceutical ingredients with
approximately 200 products in our portfolio, offering a large span
of technologies, while developing innovative molecules through our
Contract Development and Manufacturing Organization (CDMO)
activities.
Taking action for health by enabling access to essential
therapies inspires our 3,450 people every day. With strong research
and development capabilities and six manufacturing sites all
located in Europe, EUROAPI ensures API manufacturing of the highest
quality to supply customers in more than 80 countries. EUROAPI is
listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find
out more at www.euroapi.com and follow us on LinkedIn.
Forward-Looking Statements
Certain information contained in this press release is forward
looking and not historical data. These forward-looking statements
are based on opinions, projections and current assumptions
including, but not limited to, assumptions concerning the Group’s
current and future strategy, financial and non-financial future
results and the environment in which the Group operates, as well as
events, operations, future services or product development and
potential. Forward-looking statements are generally identified by
the words “expects”, “anticipates”, “believes”, “intends”,
“estimates”, “plans” and similar expressions. Forward looking
statements and information do not constitute guarantees of future
performances, and are subject to known or unknown risks,
uncertainties and other factors, a large number of which are
difficult to predict and generally outside the control of the
Group, which could cause actual results, performances or
achievements, or the results of the sector or other events, to
differ materially from those described or suggested by these
forward-looking statements. These risks and uncertainties include
those that are indicated and detailed in Chapter 3 “Risk factors”
of the Universal Registration Document approved by the French
Financial Markets Authority (Autorité des marchés financiers, AMF)
on April 14, 2023, under number R.23-009 and the Amendment to
Universal Registration Document approved by the AMF on April 25,
2023 under number R.23-015. These forward-looking statements are
given only as of the date of this press release and the Group
expressly declines any obligation or commitment to publish updates
or corrections of the forward-looking statements included in this
press release in order to reflect any change affecting the
forecasts or events, conditions or circumstances on which these
forward-looking statements are based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121179295/en/
Media Relations Contact: Laurence Bollack Mob.: +33 (0)6
81 86 80 19 mr@euroapi.com
Investor Relations Contact: Sophie Palliez-Capian Mob.:
+33 (0)6 87 89 33 51 sophie.palliez@euroapi.com
Euroapi (EU:EAPI)
Historical Stock Chart
From Apr 2024 to May 2024
Euroapi (EU:EAPI)
Historical Stock Chart
From May 2023 to May 2024